posted on 2016-08-03, 00:00authored byDD Metcalfe, R Pawankar, Steven J. Ackerman, C Akin, F Clayton, FH Falcone, GJ Gleich, AM Irani, MW Johansson, AD Klion, KM Leiferman, F Levi-Schaffer, G Nilsson, Y Okayama, C Prussin, JT Schroeder, LB Schwartz, HU Simon, AF Walls, M Triggiani
Biomarkers of disease activity have come into wide use in the study of mechanisms of human disease and in clinical medicine to both diagnose and predict disease course; as well as to monitor response to therapeutic intervention. Here we review biomarkers of the involvement of mast cells, basophils, and eosinophils in human allergic inflammation. Included are surface markers of cell activation as well as specific products of these inflammatory cells that implicate specific cell types in the inflammatory process and are of possible value in clinical research as well as within decisions made in the practice of allergy-immunology.
Funding
DDM are ADK are supported by
the Division of Intramural Research of NIAID/NIH. SJA is supported in part by
research grants from the FDA (R01FD004086), NIH (R21HL118588), American
Partnership for Eosinophilic Disorders (APFED), and University of Illinois,
Chicago. MWJ is mainly supported by research grants from the NIH (P01
HL088594 and 1U10 HL109168 [PI: N. N. Jarjour]).